CANDEL THERAPEUTICS I
5.0900
07-November-24 15:59:58
15 minutes delayed
Stocks
-0.2400
-4.50%
Today's range
5.0700 - 5.3600
ISIN
N/A
Source
NASDAQ
-
Candel Therapeutics to Present at Jefferies London Healthcare Conference 2024
07 Nov 2024 08:00:01 By Nasdaq GlobeNewswire
-
28 Oct 2024 08:00:00 By Nasdaq GlobeNewswire
-
04 Oct 2024 09:00:45 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
03 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
13 Aug 2024 08:00:01 By Nasdaq GlobeNewswire
-
18 Jun 2024 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Join Russell 3000® Index
11 Jun 2024 08:00:00 By Nasdaq GlobeNewswire
-
FDA Grants Orphan Drug Designation for CAN-3110 for the Treatment of Recurrent High-Grade Glioma
30 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Present at the Jefferies Global Healthcare Conference
22 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
20 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
14 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
25 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
11 Apr 2024 09:00:00 By Nasdaq GlobeNewswire
-
09 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
04 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
28 Mar 2024 08:05:47 By Nasdaq GlobeNewswire
-
05 Mar 2024 16:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >